Podcasts and capital
“Thoughts on the podcast industry in 2021: investors are acting as if podcasting is bigger than it really is.” | learn more
“Thoughts on the podcast industry in 2021: investors are acting as if podcasting is bigger than it really is.” | learn more
I’m not much of a twitter user but sometimes that’s where the action is! Crain’s reported “Tech incubator 1871 is launching a 12-week virtual program to help Black entrepreneurs start and grow companies.” The catch? There’s no funding. Chicago VC Ezra […]
I learned some new stock trader lingo this week. “The slang phrases paper hands and diamond hands are used to describe the risk appetite of other stock traders.” | learn more
A painstaking analysis of 27 studies, neatly summarized with key takeaways up top. “When I started looking into this subject, I predicted a person’s physical attractiveness would only have minor advantages. I was wrong. In fact, I was so wrong, […]
Machine learning is at it again… “Political orientation was correctly classified in 72% of liberal–conservative face pairs, remarkably better than chance (50%), human accuracy (55%), or one afforded by a 100-item personality questionnaire (66%).” | learn more
I’ve been exploring the Clubhouse app this week and found myself in a room dedicated to space exploration. Someone mentioned liquid breathing. I hadn’t heard of it before. It’s as crazy as it sounds. “Liquid breathing is a form of […]
“The process of mining cryptocurrencies currently relies on energy from polluting sources. Using excess power from renewable sources instead could convert waste to value and reduce financial risks.” | learn more
What great news to learn we’re once again investing in nuclear technology! | learn more
This is certainly easier to grok than Claude Shannon’s original paper. Even this simplified version requires some thinking space, making me question at times if I qualified as intelligent! | learn more
A study by Stanford researchers published in Nature found encouraging results. “The old mice, receiving an experimental drug that blocks PGE2-EP2 binding, displayed a reversal of cognitive decline, ultimately performing as well as young mice across a series of cognitive […]